Skip to Main content Skip to Navigation
Journal articles

Management of colorectal peritoneal metastases: Expert opinion

Abstract : When peritoneal metastases are diagnosed (strong agreement of experts): (i) seek advice from a multidisciplinary coordination meeting (MCM) with large experience in peritoneal disease (e.g. BIG RENAPE network); (ii) transfer (or not) the patient to a referral center with experience in hyperthermic intraperitoneal chemotherapy (HIPEC), according to the advice of the MCM. With regard to systemic chemotherapy (strong agreement of experts): (i) it should be performed both before and after surgery, (ii) for no longer than 6 months; (iii) without postoperative anti-angiogenetic drugs. With regard to cytoreductive surgery (strong agreement of experts): (i) Radical surgery requires a xiphopubic midline incision; (ii) no cytoreductive surgery via laparoscopy. With regard to HIPEC: HIPEC can be proposed for trials outside an HIPEC referral center (weak agreement between experts): (i) if surgery is radical; (ii) if the expected morbidity is "reasonable"; (iii) if the indication for HIPEC was suggested by a MCM, and; (iv) mitomycin is preferred to oxaliplatin (which cannot be recommended) for this indication.
Document type :
Journal articles
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03489199
Contributor : Accord Elsevier CCSD Connect in order to contact the contributor
Submitted on : Wednesday, July 20, 2022 - 8:20:01 PM
Last modification on : Friday, August 5, 2022 - 11:58:45 AM

File

S1878788619301274.pdf
Files produced by the author(s)

Licence


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Citation

K. Abboud, T. André, M. Brunel, M. Ducreux, C. Eveno, et al.. Management of colorectal peritoneal metastases: Expert opinion. Journal of Visceral Surgery, Elsevier, 2019, 156, pp.377 - 379. ⟨10.1016/j.jviscsurg.2019.08.002⟩. ⟨hal-03489199⟩

Share

Metrics

Record views

19

Files downloads

3